Monday, July 24, 2023 9:53:09 AM
Another mans trash is another mans gold mined, me buying very
bigly, give it time for acquisitions to generate revs, let see how next couple
qtrs do...
bigly, give it time for acquisitions to generate revs, let see how next couple
qtrs do...
Recent COSM News
- Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Prog • ACCESS Newswire • 05/14/2026 01:00:00 PM
- Cosmos Health Announces Withdrawal of Registration Statement on Form S-1 • ACCESS Newswire • 05/12/2026 02:15:00 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 05/11/2026 08:30:32 PM
- Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months • ACCESS Newswire • 05/11/2026 06:25:00 PM
- Cosmos Health Introduces Fort18 in the United States - A Men's Sexual Stamina Supplement Expanding the 18 Series into Men's Wellness • ACCESS Newswire • 05/06/2026 02:35:00 PM
- Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months • ACCESS Newswire • 04/30/2026 04:50:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/25/2026 12:33:19 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 04/24/2026 08:30:45 PM
- Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products • ACCESS Newswire • 04/21/2026 04:50:00 PM
- Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio • ACCESS Newswire • 04/20/2026 02:55:00 PM
- Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health • ACCESS Newswire • 04/17/2026 06:00:00 PM
- Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30% • ACCESS Newswire • 04/16/2026 07:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/16/2026 03:15:18 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 08:34:41 PM
- Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 20 • ACCESS Newswire • 04/15/2026 01:25:00 PM
- Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units • ACCESS Newswire • 04/13/2026 04:50:00 PM
- Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months • ACCESS Newswire • 04/10/2026 01:40:00 PM
- Cosmos Health Continues Expansion in the United States with Q2 Launch of Liv18 - a Clinically Proven, Patented Supplement for Liver Fat Reduction • ACCESS Newswire • 04/08/2026 03:10:00 PM
- Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets • ACCESS Newswire • 04/01/2026 03:42:00 PM
- Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000 • GlobeNewswire Inc. • 03/11/2026 05:45:00 PM
- Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000 • GlobeNewswire Inc. • 03/10/2026 01:00:00 PM
- Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board • GlobeNewswire Inc. • 02/24/2026 05:30:00 PM
- Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value • GlobeNewswire Inc. • 02/19/2026 04:30:00 PM
- Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK’s Second-Largest Beauty and Health Retailer • GlobeNewswire Inc. • 02/18/2026 06:45:00 PM
